{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:51:27Z","timestamp":1776408687520,"version":"3.51.2"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-06889-2","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T05:46:05Z","timestamp":1773467165000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of venetoclax-obinutuzumab treatment in achieving remission of acquired von Willebrand syndrome in chronic lymphocytic leukemia"],"prefix":"10.1007","volume":"105","author":[{"given":"Francesca","family":"Morelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Linari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara Maria","family":"Rapolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Attanasio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Salvianti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Sanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"issue":"S2","key":"6889_CR1","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1002\/AJH.26585","volume":"97","author":"MJ Gordon","year":"2022","unstructured":"Gordon MJ, Ferrajoli A (2022) Unusual complications in the management of chronic lymphocytic leukemia. Am J Hematol 97(S2):S26\u2013S34. https:\/\/doi.org\/10.1002\/AJH.26585","journal-title":"Am J Hematol"},{"issue":"4","key":"6889_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/AJH.10298","volume":"72","author":"S Kumar","year":"2003","unstructured":"Kumar S, Pruthi RK, Nichols WL (2003) Acquired von willebrand\u2019s syndrome: a single institution experience. Am J Hematol 72(4):243\u2013247. https:\/\/doi.org\/10.1002\/AJH.10298","journal-title":"Am J Hematol"},{"key":"6889_CR3","doi-asserted-by":"publisher","unstructured":"Jung M, Rice L (2011) Unusual autoimmune nonhematologic complications in chronic lymphocytic leukemia. Clin Lymphoma Myeloma Leuk 11 Suppl 1(SUPPL.1). https:\/\/doi.org\/10.1016\/J.CLML.2011.02.005","DOI":"10.1016\/J.CLML.2011.02.005"},{"issue":"12","key":"6889_CR4","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1080\/10428194.2019.1612063","volume":"60","author":"I Innocenti","year":"2019","unstructured":"Innocenti I, Morelli F, Autore F et al (2019) Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax. Leuk Lymphoma 60(12):3078\u20133080. https:\/\/doi.org\/10.1080\/10428194.2019.1612063","journal-title":"Leuk Lymphoma"},{"key":"6889_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/HAE.14995","volume":"30","author":"A Tiede","year":"2024","unstructured":"Tiede A, Susen S, Lisman T (2024) Acquired bleeding disorders. Haemophilia 30:29\u201338. https:\/\/doi.org\/10.1111\/HAE.14995","journal-title":"Haemophilia"},{"issue":"2","key":"6889_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1055\/S-0033-1334867\/ID\/JR01958-16\/BIB","volume":"39","author":"A Federici","year":"2013","unstructured":"Federici A, Budde U, Castaman G, Rand J, Tiede A (2013) Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: A 2013 update. Semin Thromb Hemost 39(2):191\u2013201. https:\/\/doi.org\/10.1055\/S-0033-1334867\/ID\/JR01958-16\/BIB","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"6889_CR7","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1111\/HAE.13382","volume":"24","author":"E Biguzzi","year":"2018","unstructured":"Biguzzi E, Siboni SM, Peyvandi F (2018) Acquired von Willebrand syndrome and response to Desmopressin. Haemophilia 24(1):e25\u2013e28. https:\/\/doi.org\/10.1111\/HAE.13382","journal-title":"Haemophilia"},{"issue":"6","key":"6889_CR8","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1016\/J.CLML.2021.01.007","volume":"21","author":"R Khalife","year":"2021","unstructured":"Khalife R, Aw A, Duffett L et al (2021) To treat or not? Remission induction of acquired von Willebrand syndrome secondary to chronic lymphocytic leukemia: A case report. Clin Lymphoma Myeloma Leuk 21(6):e493\u2013e496. https:\/\/doi.org\/10.1016\/J.CLML.2021.01.007","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"6889_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/J.BCMD.2019.04.009","volume":"77","author":"L Hegerova","year":"2019","unstructured":"Hegerova L, He F, Zantek ND, Vercellotti GM, Holtan SG, Reding MT (2019) Reversal of acquired von Willebrand syndrome with allogeneic stem cell transplant for chronic lymphocytic leukemia. Blood Cells Mol Dis 77:109\u2013112. https:\/\/doi.org\/10.1016\/J.BCMD.2019.04.009","journal-title":"Blood Cells Mol Dis"},{"issue":"18","key":"6889_CR10","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1182\/blood.2024024631","volume":"144","author":"O Al-Sawaf","year":"2024","unstructured":"Al-Sawaf O, Robrecht S, Zhang C, Olivieri S, Chang YM, Fink AM, Tausch E, Schneider C, Ritgen M, Kreuzer KA, Sivchev L, Niemann CU, Schwarer A, Loscertales J, Weinkove R, Strumberg D, Kilfoyle A, Manzoor BS, Jawaid D, Emechebe N, Devine J, Boyer M, Runkel ED, Eichhorst B, Stilgenbauer S, Jiang Y, Hallek M, Fischer K (2024) Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized phase 3 CLL14 study. Blood 144(18):1924\u20131935. https:\/\/doi.org\/10.1182\/blood.2024024631PMID: 39082668; PMCID: PMC11551846","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06889-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-06889-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06889-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:59:14Z","timestamp":1776405554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-06889-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":10,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["6889"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-06889-2","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"24 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required due to the nature of the case report itself.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from the patient to publish this report in accordance with the journal\u2019s patient consent policy.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permission to reproduce material from other sources"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"177"}}